ABATA Trademark
Trademark Overview
On Wednesday, December 18, 2024, a trademark application was filed for ABATA with the United States Patent and Trademark Office. The USPTO has given the ABATA trademark a serial number of 98909678. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, December 18, 2024. This trademark is owned by Abata Therapeutics, Inc.. The ABATA trademark is filed in the Pharmaceutical Products and Treatment & Processing of Materials Services categories with the following description:
Custom manufacture of therapeutic drugs, namely, custom manufacture of cell and gene therapies; custom manufacturing for others, namely, manufacturing of pharmaceutical preparations for health care, for the treatment of humans suffering from diseases treated by cell therapy or gene therapy or regenerative medicine products, more specifically medicines for human use as well as medicines for experimental medical and therapeutic uses, biological products for experimental purposes, preparations for cell therapy, gene therapy, and medicines for innovative therapies
Pharmaceutical preparations for cell therapy, namely pharmaceutical preparations for T cell therapy; pharmaceutical preparations and vaccines for use in gene therapy and cell therapy; biological preparations for use in medical and clinical gene therapy and cell therapy for the treatment of cancer, autoimmune diseases, neurological disorders, inflammatory conditions, transplant complications, and immunological disorders; pharmaceutical products for the prevention and treatment of cancer, autoimmune diseases, neurological disorders, inflammatory conditions, transplant complications, and immunological disorders; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer, autoimmune diseases, neurological disorders, inflammatory conditions, transplant complications, and immunological disorders; biological preparations for the treatment of cancer, autoimmune diseases, neurological disorders, inflammatory disorders, transplant complications, and immunological dis...
General Information
| Serial Number | 98909678 |
| Word Mark | ABATA |
| Filing Date | Wednesday, December 18, 2024 |
| Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
| Status Date | Wednesday, December 18, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Custom manufacture of therapeutic drugs, namely, custom manufacture of cell and gene therapies; custom manufacturing for others, namely, manufacturing of pharmaceutical preparations for health care, for the treatment of humans suffering from diseases treated by cell therapy or gene therapy or regenerative medicine products, more specifically medicines for human use as well as medicines for experimental medical and therapeutic uses, biological products for experimental purposes, preparations for cell therapy, gene therapy, and medicines for innovative therapies |
| Goods and Services | Pharmaceutical preparations for cell therapy, namely pharmaceutical preparations for T cell therapy; pharmaceutical preparations and vaccines for use in gene therapy and cell therapy; biological preparations for use in medical and clinical gene therapy and cell therapy for the treatment of cancer, autoimmune diseases, neurological disorders, inflammatory conditions, transplant complications, and immunological disorders; pharmaceutical products for the prevention and treatment of cancer, autoimmune diseases, neurological disorders, inflammatory conditions, transplant complications, and immunological disorders; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer, autoimmune diseases, neurological disorders, inflammatory conditions, transplant complications, and immunological disorders; biological preparations for the treatment of cancer, autoimmune diseases, neurological disorders, inflammatory disorders, transplant complications, and immunological disorders; chemical and biochemical preparations for medical purposes, specifically, for the treatment and diagnosis of cancer, autoimmune diseases, neurological disorders, inflammatory conditions, transplant complications, and immunological disorders; biochemical, namely, monoclonal antibodies for medical purposes, specifically, for the treatment and diagnosis of cancer, autoimmune diseases, neurological disorders, inflammatory conditions, transplant complications, and immunological disorders |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, December 18, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, December 18, 2024 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Abata Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Watertown, MA 02472 |
Trademark Events
| Event Date | Event Description |
| Wednesday, December 18, 2024 | NEW APPLICATION ENTERED |
